Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2017 Dec;140(6):e20164040.
doi: 10.1542/peds.2016-4040. Epub 2017 Nov 3.

Presentation and Diagnosis of Tuberous Sclerosis Complex in Infants

Affiliations
Multicenter Study

Presentation and Diagnosis of Tuberous Sclerosis Complex in Infants

Peter E Davis et al. Pediatrics. 2017 Dec.

Abstract

Objectives: Tuberous sclerosis complex (TSC) is a neurocutaneous genetic disorder with a high prevalence of epilepsy and neurodevelopmental disorders. TSC can be challenging to diagnose in infants because they often do not show many clinical signs early in life. In this study, we describe the timing and pattern of presenting and diagnostic features in a prospective longitudinal study of infants with TSC.

Methods: Two multicenter, prospective studies enrolled 130 infants with definite TSC by clinical or genetic criteria and followed them longitudinally up to 36 months of age. Periodic study visits included medical and seizure histories, physical and neurologic examinations, and developmental assessments. Ages at which major and minor features of TSC and seizures were first identified were analyzed.

Results: The most common initial presenting features of TSC were cardiac rhabdomyomas (59%) and hypomelanotic macules or other skin findings (39%), and 85% of infants presented with either or both. Ultimately, the most prevalent diagnostic TSC features were hypomelanotic macules (94%), tubers or other cortical dysplasias (94%), subependymal nodules (90%), and cardiac rhabdomyomas (82%). Thirty-five percent of infants presented prenatally, 41% presented at birth or within the first month of life, and 74% met criteria for TSC diagnosis at or within 30 days of presentation. Seizure onset occurred before or at initial presentation in only 15% of infants, but 73% developed epilepsy within the first year of life.

Conclusions: Infants with TSC can often be identified early, before the onset of neurologic sequelae, enabling earlier diagnosis, surveillance, and possibly disease-modifying treatment.

PubMed Disclaimer

Conflict of interest statement

POTENTIAL CONFLICT OF INTEREST: Dr Bebin serves on the scientific advisory board for Novartis Pharmaceuticals Corporation and GW Pharmaceuticals and receives clinical research support from both. Dr Wu serves on the professional advisory board for the Tuberous Sclerosis Alliance, has received honoraria from and serves on the scientific advisory board and the speakers’ bureau for Novartis and H. Lundbeck A/S, and has received research support from the Tuberous Sclerosis Alliance, Novartis, and Today’s and Tomorrow’s Children Fund. Dr Sahin has received research funding from F. Hoffman-La Roche AG, Novartis, Pfizer, and LAM Therapeutics; has served on the scientific advisory board of Sage Therapeutics Inc. and PTEN Research Foundation; and serves on the professional advisory board of the Tuberous Sclerosis Alliance. Dr Krueger has received research funding from Novartis, the Clack Foundation Inc., and the Tuberous Sclerosis Alliance; has received consultant fees from Novartis; and serves on the professional advisory board of the Tuberous Sclerosis Alliance. The other authors have indicated they have no potential conflicts of interest to disclose.

Figures

FIGURE 1
FIGURE 1
Prevalence of TSC features at initial presentation. Thirty-six infants (28%) had >1 initial presenting feature.
FIGURE 2
FIGURE 2
Age of onset or recognition of the most prevalent TSC features in infants. Hypomelanotic macules, tubers, SENs, and cardiac rhabdomyomas are often seen before the onset of seizures, whereas other manifestations are more commonly first seen later in life.
FIGURE 3
FIGURE 3
Time from initial presentation to first seizure.
FIGURE 4
FIGURE 4
Seizure onset prevalence in TSC by age and seizure type. Infantile spasms had the highest rate of onset between 3 and 9 months, whereas focal seizures had a more constant rate of onset up to 21 months, and other seizure types had a rate of up to 26 months.
FIGURE 5
FIGURE 5
Frequency of organ system involvement in all subjects and in LCs. Vertex size is proportional to the prevalence of organ system involvement in a class. Edge width is proportional to relative co-occurrence of adjoining organ systems. Note the different patterns and prevalences of organ system involvement and co-occurrence in each class.

Comment in

References

    1. Sahin M, Henske EP, Manning BD, et al. ; Tuberous Sclerosis Complex Working Group to Update the Research Plan . Advances and future directions for tuberous sclerosis complex research: recommendations from the 2015 Strategic Planning Conference. Pediatr Neurol. 2016;60:1–12 - PMC - PubMed
    1. Krueger DA, Northrup H; International Tuberous Sclerosis Complex Consensus Group . Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol. 2013;49(4):255–265 - PMC - PubMed
    1. Jülich K, Sahin M. Mechanism-based treatment in tuberous sclerosis complex. Pediatr Neurol. 2014;50(4):290–296 - PMC - PubMed
    1. Osborne JP, Fryer A, Webb D. Epidemiology of tuberous sclerosis. Ann N Y Acad Sci. 1991;615(1):125–127 - PubMed
    1. Curatolo P, Maria BL. Tuberous sclerosis. Handb Clin Neurol. 2013;111:323–331 - PubMed

Publication types